Neurim Pharmaceuticals

Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. It provides Circadin, a prolonged release melatonin formulation for the treatment of insomnia. Additionally, the company offers Slenyto, an age-appropriate formulation for the treatment of insomnia in children and adolescents with autism spectrum disorder (ASD) or Smith-Magenis syndrome.